Model
Edge
4D Molecular Therapeutics
0001834021
Filing Type
144
Filing Date
6/23/2024
Updated
6/24/24, 3:39 PM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities